Device Devices

Teg5000 Hemostasis Analyzer

Payments companies reported to CMS as associated with Teg5000 Hemostasis Analyzer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$170Kassociated payments (2023-2025)
290clinicians with associated payments
2companies reporting

By year

2023 $90K
2024 $12K
2025 $68K

Payments reported as associated with Teg5000 Hemostasis Analyzer, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Anesthesiology $76K
Surgery $20K
Trauma Surgery $19K
Thoracic Surgery (Cardiothoracic Vascular Surgery) $18K
Clinical Cardiac Electrophysiology $11K
Blood Banking & Transfusion Medicine $8,397

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Teg5000 Hemostasis Analyzer

These are the largest totals companies reported as associated with Teg5000 Hemostasis Analyzer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Brian Cho Baltimore, MD Anesthesiology $25,905.41
Michael Moront Toledo, OH Thoracic Surgery (Cardiothoracic Vascular Surgery) $17,845.39
Roman Dudaryk Miami, FL Anesthesiology $13,537.58
Babak Sarani Washington, DC Surgery $11,615.90
Bryan Cotton Nashville, TN Trauma Surgery $11,582.00
Steven Frank Towson, MD Anesthesiology $10,812.53
Courtney Maxey Jones Johnson City, NY Anesthesiology $10,143.70
Amin Al-Ahmad Austin, TX Clinical Cardiac Electrophysiology $10,108.85
Evan Pivalizza Houston, TX Anesthesiology $8,539.16
Paul Ness Baltimore, MD Blood Banking & Transfusion Medicine $8,397.00

Prescribed Teg5000 Hemostasis Analyzer?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.